Skip to main content
Clinical Trials/NCT05181423
NCT05181423
Recruiting
Not Applicable

Identification of Noninvasive Biomarkers for Neonates Undergoing Abdominal Surgery

West China Hospital1 site in 1 country2,000 target enrollmentJanuary 1, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Biomarkers
Sponsor
West China Hospital
Enrollment
2000
Locations
1
Primary Endpoint
Value of non-invasive biomarkers
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

To identify the potential serum and radiological biomarkers with regard to neonates undergoing abdominal surgery, and to further evaluate the prognostic value of these markers.

Detailed Description

First, the investigators will collect serum biomarkers in neonate patients receiving abdominal surgery. Then the investigators will identify the characteristics and change of biomarkers expressed in neonate patients before and after abdominal surgery. The investigators will further evaluate the prognostic value of these markers for neonate patients receiving abdominal surgery.

Registry
clinicaltrials.gov
Start Date
January 1, 2021
End Date
December 31, 2024
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Yuhan Yang

Associate Professor

West China Hospital

Eligibility Criteria

Inclusion Criteria

  • Age up to 18 years old
  • With written informed consent

Exclusion Criteria

  • Clinical data missing
  • Without written informed consent

Outcomes

Primary Outcomes

Value of non-invasive biomarkers

Time Frame: At least 5-year follow up

These markers will be collected in association with the prognostication for neonates before and after surgery.

Study Sites (1)

Loading locations...

Similar Trials